Bulletin
Investor Alert
×

Amgen Inc.

NAS: AMGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209157011/composite

$

195.06

Change

+0.02 +0.01%

Volume

Volume 72,416

Sep 18, 2019, 6:41 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209157011/composite

Today's close

$ 196.72

$ 195.04

Change

-1.68 -0.85%

Day low

Day high

$193.26

$196.83

Open
Open: 196.36

52 week low

52 week high

$166.30

$211.90

Open

Market cap

$117.97B

Average volume

3.26M

P/E ratio

15.44

Rev. per Employee

$1.11M

EPS

12.63

Dividend

1.45

Div yield

2.97%

Ex dividend date

8/14/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/amgn

MarketWatch News on AMGN

  1. Amgen stock price target raised to $198 from $191 at J.P. Morgan

    7:41 a.m. Sept. 10, 2019

    - Tomi Kilgore

  2. Amgen Falls as Cancer-Drug Report Fails to Impress Investors

    8:59 a.m. Sept. 9, 2019

    - Josh Nathan-Kazis

  3. Alexion Loses in Patent Push, but Stock Doesn’t Stumble

    10:09 a.m. Sept. 6, 2019

    - Josh Nathan-Kazis

  4. Amgen Now Getting Recognition for Its Otezla Deal

    9:24 a.m. Aug. 29, 2019

    - Josh Nathan-Kazis

  5. Amgen stock price target raised to $198 vs. $191 at JPMorgan

    8:36 a.m. Aug. 29, 2019

    - Ciara Linnane

  6. Amgen Faces Trouble in the Anti-Cholesterol-Drug Battle, Analyst Says

    10:43 a.m. Aug. 28, 2019

    - Josh Nathan-Kazis

  7. Bristol-Meyers Deal for Celgene Moves Ahead

    9:14 a.m. Aug. 26, 2019

    - Josh Nathan-Kazis

  8. Dish Network Stock Jumps as Dow Rebounds

    8:58 a.m. Aug. 26, 2019

    - Teresa Rivas

  9. Amgen to buy Celgene's Otezla for $13.4 billion

    6:50 a.m. Aug. 26, 2019

    - Tomi Kilgore

  10. Amgen to buy Celgene's Otzela psoriasis treatment for $13.4 bln in cash

    6:32 a.m. Aug. 26, 2019

    - Tomi Kilgore

  11. Amgen Stock’s Recent Rally Will Continue. Here’s Why.

    10:03 a.m. Aug. 22, 2019

    - Teresa Rivas

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/amgn

Other News on AMGN

  1. Merck's Keytruda Combo Gets FDA Nod for Endometrial Carcinoma

    10:41 a.m. Today

    - Zacks.com

  2. Biotech Stock Roundup: BIIB Halts AD Study, AMGN Posts Positive MM Drug Data & More

    10:33 a.m. Today

    - Zacks.com

  3. Healthcare And Biotechnology Dashboard - Update

    2:10 a.m. Today

    - Seeking Alpha

  4. Adaptive Bio inks deal for clonoSEQ Assay with Amgen

    8:30 a.m. Sept. 17, 2019

    - Seeking Alpha

  5. Top Stock Picks for Week of September 16, 2019

    3:38 p.m. Sept. 16, 2019

    - Zacks.com

  6. Aimmune's Peanut Allergy Drug Gets FDA Committee's Support

    1:18 p.m. Sept. 16, 2019

    - Zacks.com

  7. ADC Therapeutics Begins U.S. IPO Process

    12:48 p.m. Sept. 16, 2019

    - Seeking Alpha

  8. Vertex Gains Reimbursement for Orkambi & Symkevi in Scotland

    11:08 a.m. Sept. 13, 2019

    - Zacks.com

  9. Celgene's (CELG) Leukemia Candidate Meets Endpoints in Study

    10:30 a.m. Sept. 13, 2019

    - Zacks.com

  10. Amgen Is On The Right Track With Its Own Biosimilar To Rituxan

    9:45 a.m. Sept. 13, 2019

    - Seeking Alpha

  11. William Blair Maintains Their Hold Rating on Amgen Inc (AMGN)

    9:32 a.m. Sept. 13, 2019

    - SmarterAnalyst

  12. REGENXBIO (RGNX) Catches Eye: Stock Jumps 5.8%

    8:44 a.m. Sept. 13, 2019

    - Zacks.com

  13. Aprea Therapeutics Files For U.S. IPO

    6:22 p.m. Sept. 12, 2019

    - Seeking Alpha

  14. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/amgn

Press Releases on AMGN

  1. Biosimilars Market 2019 - 2024 Trends, Analysis, Market Forecast

    9:03 a.m. Today

    - Heraldkeepers

  2. Multiple Myeloma Drugs Market Size 2019| Global Industry Analysis and Opportunity Assessment 2016-2026

    7:58 a.m. Today

    - Brandessence Market Research

  3. BeyondSpring Provides Operational Update and Second-Quarter 2019 Financial Results

    7:00 a.m. Today

    - GlobeNewswire

  4. Biologics Market to Have A Promising Future Ahead!

    6:16 a.m. Sept. 17, 2019

    - AmericaNewsHour

  5. Global Cancer Treatment Drugs Market (2019-2024) Analysis By Region

    5:07 a.m. Sept. 17, 2019

    - marketresearch.biz

  6. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.